NORTHERN TRUST CORP - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 25 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q3 2023$153,012
-3.7%
31,355
+15.6%
0.00%
Q2 2023$158,894
+39.9%
27,1150.0%0.00%
Q1 2023$113,612
-14.5%
27,115
-13.2%
0.00%
Q4 2022$132,825
+681.3%
31,253
+195.3%
0.00%
Q3 2022$17,000
+41.7%
10,5840.0%0.00%
Q2 2022$12,000
-53.8%
10,5840.0%0.00%
Q1 2022$26,000
-16.1%
10,5840.0%0.00%
Q4 2021$31,000
-27.9%
10,5840.0%0.00%
Q3 2021$43,000
-15.7%
10,5840.0%0.00%
Q2 2021$51,00010,5840.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q4 2022
NameSharesValueWeighting ↓
EMC Capital Management 123,915$5270.47%
SABBY MANAGEMENT, LLC 34,500$146,6250.13%
XTX Topco Ltd 58,475$248,5190.05%
TANG CAPITAL MANAGEMENT LLC 24,125$102,5310.02%
Tower Research Capital LLC (TRC) 10,037$430.00%
TWO SIGMA INVESTMENTS, LP 47,035$199,8990.00%
Cubist Systematic Strategies, LLC 38,600$164,0500.00%
Renaissance Technologies 20,300$860.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 9,299$39,5210.00%
SIMPLEX TRADING, LLC 10,303$430.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders